The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract, with a potential value of $39,088.72, is for the delivery of BIKTARVY 50-200-25 MG TABLET in 30-count packages. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp,...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $15,672.81, is for the provision of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product. This delivery order is placed under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide BIKTARVY 50-200-25 MG TABLET in 30-count units. The $258,524.84 award has a completion date of August 13, 2021 and was not set aside. AmerisourceBergen Drug Corp, a for-profit organization, has been awarded numerous pharmaceutical and medical supply contracts by DLA Troop Support Medical to support...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of BIKTARVY 50-200-25 MG TABLET UU 30S pharmaceuticals. The contract has a completion date of January 30, 2024 and a potential value of $9,843.22. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of up to...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product BIKTARVY 50-200-25 MG TABLET in 30-count packages. The $133,974.72 contract has an August 31, 2022 completion date and was awarded on August 30, 2022. No set-aside designation was used. Amerisourcebergen Drug Corp has received numerous prior DLA contracts to supply...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of BIKTARVY 50-200-25 MG TABLET in 30-count units. The contract has a ceiling value of $22,616.24 and a period of performance through April 15, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of BIKTARVY 50-200-25 MG TABLET. The $32,373.58 contract has an ultimate completion date of April 3, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 with a performance period...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the pharmaceutical distribution company AmerisourceBergen Corporation. The contract, valued at $4,561.72, is for the provision of BIKTARVY 50-200-25 MG TABLET in 30-count units. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded solely to AmerisourceBergen Drug Corp, which serves as the...
The U.S. Defense Logistics Agency (DLA) awarded a $10,446.65 firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply BIKTARVY 50-200-25 MG TABLET medication. This order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to AmerisourceBergen Drug Corp through December 31, 2025. The IDC serves as the primary contract vehicle for AmerisourceBergen to deliver pharmaceutical...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide BIKTARVY 50-200-25 MG TABLET UU 30S. The potential value of this order is $8,987.46, with a completion date of February 14, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...